Abbott Laboratories Share Price & Technical Analysis

ABT · $86.67 (-0.85%)

Healthcare / Medical Devices

AI Score 30 · Bearish

$86.67

-0.85%

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spas

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-4% return in May, -3% avg return in past 3 year May month.

-33% return in 2026, 6% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-12%7%-11%-12%-4%-33%
2512%9%-4%-1%3%2%-7%6%1%-8%4%-3%15%
243%5%-4%-7%-3%2%2%6%1%-1%-1%-5%-2%
230%-8%1%10%-8%7%3%-7%-6%-1%10%6%5%
22-9%-5%-2%-4%4%-8%1%-5%-5%1%8%1%-24%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 30/100

Bearish · Downtrend · Weak

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$145.93B

P/E ratio

23.47

52W high

$139.1

52W low

$81.97

Volume

1,02,37,646

Beta

0.65

Related stocks in Healthcare

Frequently asked questions

What is Abbott Laboratories share price today?
Abbott Laboratories (ABT) last traded around $86.67 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does ABT have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ABT. Download the app for real-time alerts.
How can I analyze Abbott Laboratories stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro